// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "pooled sample MS EM XL EW MUST OF DOID RECOMMEND file your CL OPTIONAL NOTE MT SP EFO TO VCF disease stage MINOR SN INFORMATION developmental stage BTO TMT ENVO ... LC TAB SH INITIATIVE SHALL NCE CF PS AS COLUMN XML VK THE proteomics data acquisition method IDF FITNESS organism part PATCH MERCHANTABILITY PTM alkylation reagent instrument IMPLIED PURPOSE WARRANTY MC PSI PRIDE:0000659 FOR organism ROW characteristics ISA LI ancestry category ID BUT data file EBI CID reduction reagent MAJOR HEREIN source name_ and _assay name individual exclamation fractionation method IMPORTANT III URI BRENDA RIGHTS LIMITED CT EXPRESS cleavage agent details BMC STANDARDS HF ZFA BE PRIDE OR CS HANCESTRO MHC NOT biological replicate PATO COULD WILL SHOULD PEPTIDESEQ PP THAT IS WARRANTIES SILAC biosample accession number PMID depletion dissociation method SDRF source name mass technical replicate cell type PMCID RFC PRM sex PO MONDO collision energy DTT NT AC HCD DJ JA RAW MAGE sample ANY HTML README RECOMMENDED MOD QY DIA REQUIRES MS:1001251 SWATH II CPTAC MIAME INFRINGE MAY CELL NCBI CLO age SRM CV UBERON ALL USE INCLUDING DISCLAIMS HUPO TA disease PARTICULAR FDR DDA spiked compound fraction identifier IAA PROTEOMICS TIP label URL CN replicate REQUIRED"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "pooled sample MS EM XL EW MUST OF DOID RECOMMEND CL OPTIONAL MT SP EFO TO VCF disease stage MINOR SN INFORMATION BTO TMT ENVO ... LC TAB SH INITIATIVE SHALL NCE CF PS AS COLUMN VK THE proteomics data acquisition method IDF FITNESS organism part PATCH MERCHANTABILITY PTM alkylation reagent instrument IMPLIED PURPOSE WARRANTY MC PSI PRIDE:0000659 FOR organism ROW ISA LI ancestry category BUT data file EBI CID reduction reagent MAJOR HEREIN individual fractionation method III URI BRENDA RIGHTS LIMITED CT EXPRESS cleavage agent details BMC STANDARDS HF ZFA BE PRIDE OR CS HANCESTRO MHC NOT biological replicate PATO COULD WILL SHOULD PEPTIDESEQ PP THAT IS WARRANTIES SILAC biosample accession number PMID depletion dissociation method SDRF mass technical replicate cell type PMCID RFC PRM sex PO MONDO collision energy DTT NT AC HCD DJ JA RAW MAGE ANY HTML README RECOMMENDED MOD QY DIA REQUIRES MS:1001251 SWATH II CPTAC MIAME INFRINGE MAY CELL NCBI CLO age SRM CV UBERON ALL USE INCLUDING DISCLAIMS HUPO TA disease PARTICULAR FDR DDA spiked compound fraction identifier IAA PROTEOMICS label URL CN REQUIRED"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "UBERON:0000178 UBERON:0000955 MUST PATO:0000384 UBERON:0000948 APP DOID DSS CL:0000084 CL UBERON:0000310 NOTE PATO:0000461 CL:0000623 EFO CL:0000233 UBERON:0002107 developmental stage CL:0000813 CL:0000788 MONDO:0005105 UBERON:0001977 xenograft UBERON:0002048 MONDO:0005575 MONDO:0005301 CL:0000232 MONDO:0005138 organism part CL:0000913 PTM COVID MONDO:0100096 enrichment process organism CL:0000540 MONDO:0004975 CL:0000576 UBERON:0001088 ancestry category ID MONDO:0005148 UBERON:0001969 UBERON:0001155 CL:0000898 CL:0000624 compound MONDO:0004989 CL:0000815 individual UBERON:0002097 CL:0000057 exclamation IMPORTANT UBERON:0001359 NSG MONDO:0005180 MONDO:0004946 HANCESTRO CL:0000066 biological replicate MONDO:0008383 PATO SHOULD CL:0000625 PATO:0001340 depletion PATO:0000383 SDRF NK source name cell type sex PO MONDO CSF CL:0000451 CL:0000787 CL:0000236 PDX MAY NCBI age UBERON ALL CML CL:0000182 disease model disease CL:0000235 synthetic peptide TIP URL lib UBERON:0002113"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "UBERON:0000178 UBERON:0000955 MUST PATO:0000384 UBERON:0000948 APP DOID DSS CL:0000084 CL UBERON:0000310 PATO:0000461 CL:0000623 EFO CL:0000233 UBERON:0002107 developmental stage CL:0000813 CL:0000788 MONDO:0005105 UBERON:0001977 xenograft UBERON:0002048 MONDO:0005575 MONDO:0005301 CL:0000232 MONDO:0005138 organism part CL:0000913 PTM COVID MONDO:0100096 enrichment process organism CL:0000540 MONDO:0004975 CL:0000576 UBERON:0001088 ancestry category ID MONDO:0005148 UBERON:0001969 UBERON:0001155 CL:0000898 CL:0000624 compound MONDO:0004989 CL:0000815 individual UBERON:0002097 CL:0000057 UBERON:0001359 NSG MONDO:0005180 MONDO:0004946 HANCESTRO CL:0000066 biological replicate MONDO:0008383 PATO SHOULD CL:0000625 PATO:0001340 depletion PATO:0000383 SDRF NK source name cell type sex PO MONDO CSF CL:0000451 CL:0000787 CL:0000236 PDX MAY NCBI age UBERON ALL CML CL:0000182 disease model disease CL:0000235 synthetic peptide URL UBERON:0002113"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C81327 weight GDPR HIPAA HANCESTRO:0010 BMI CHEBI:28748 AJCC TNM NCIT:C15329 NCIT:C18058 NOTE NCIT:C15632 MONDO:0004995 EFO NCIT:C53555 treatment status NCIT:C18213 disease stage NCIT:C28078 UO NCIT:C71732 treatment response PREFERRED NCIT:C14169 NCIT:C14168 HANCESTRO:0009 NCIT:C53556 NCIT:C28077 NCIT:C27966 smoking status NCIT:C68804 organism part CHEBI:41774 NCIT:C53554 HANCESTRO:0005 diet MONDO:0005300 NCIT:C15313 menopausal status TNM staging organism secondary condition breast cancer subtype ancestry category ID MONDO:0005148 gestational age compound NCIT:C28079 time post treatment treatment IV NCIT:C4870 NCIT:C65106 individual NCIT:C18206 PR exclamation III IMPORTANT NCIT:C14167 HANCESTRO:0006 PD pre-existing condition sampling time point NCIT:C65107 HANCESTRO ethnicity Ann Arbor stage tumor grade ER NCIT:C15445 SDRF MONDO:0011122 NCIT:C28076 sex NCIT:C15262 NCIT:C65108 Dukes stage MONDO CHEBI:6801 MONDO:0005044 height MONDO:0002050 body mass index NCIT:C27970 CHEBI:27899 ACE MONDO:0004979 medication history II NCIT:C14174 NCI NCIT:C27971 age NCIT:C53553 NCIT:C62723 prior treatment pregnancy status disease dose NCIT NCIT:C81328 NCIT:C28054 NCIT:C16358 alcohol consumption"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C81327 weight GDPR HIPAA HANCESTRO:0010 BMI CHEBI:28748 AJCC TNM NCIT:C15329 NCIT:C18058 NCIT:C15632 MONDO:0004995 EFO NCIT:C53555 treatment status NCIT:C18213 disease stage NCIT:C28078 UO NCIT:C71732 treatment response PREFERRED NCIT:C14169 NCIT:C14168 HANCESTRO:0009 NCIT:C53556 NCIT:C28077 NCIT:C27966 smoking status NCIT:C68804 organism part CHEBI:41774 NCIT:C53554 HANCESTRO:0005 diet MONDO:0005300 NCIT:C15313 menopausal status TNM staging organism secondary condition breast cancer subtype ancestry category ID MONDO:0005148 gestational age compound NCIT:C28079 time post treatment treatment IV NCIT:C4870 NCIT:C65106 individual NCIT:C18206 PR III NCIT:C14167 HANCESTRO:0006 PD pre-existing condition sampling time point NCIT:C65107 HANCESTRO ethnicity Ann Arbor stage tumor grade ER NCIT:C15445 SDRF MONDO:0011122 NCIT:C28076 sex NCIT:C15262 NCIT:C65108 Dukes stage MONDO CHEBI:6801 MONDO:0005044 height MONDO:0002050 body mass index NCIT:C27970 CHEBI:27899 ACE MONDO:0004979 medication history II NCIT:C14174 NCI NCIT:C27971 age NCIT:C53553 NCIT:C62723 prior treatment pregnancy status disease dose NCIT NCIT:C81328 NCIT:C28054 NCIT:C16358 alcohol consumption"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "AC exclamation MS TOF IMPORTANT RAW MS:1001309 proteomexchange accession number ST MS:1001303 proteomics data acquisition method XL URI sample MS:1001313 MUST RECOMMENDED file uri MS1 scan range cleavage agent details LTQ MOD MS:1001917 precursor mass tolerance ELISA fragment mass tolerance DIA HF SCIEX UNIMOD:4 UNIMOD:35 PRIDE MS:1001251 UNIMOD:737 UNIMOD MM RPPA UNIMOD:1 KR instrument MS2 analyzer type CS NOTE scan window lower limit MT scan window upper limit SRM MRM PSI UNIMOD:21 MSD MGF SHOULD FTP PP SILAC TA MS:1001306 fraction ID TMT DDA TS data file fraction identifier SDRF PRIDE:0000663 TIP modification parameters technical replicate label URL PRM CF REQUIRED NT"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "AC MS TOF RAW MS:1001309 proteomexchange accession number ST MS:1001303 proteomics data acquisition method XL URI MS:1001313 MUST RECOMMENDED file uri MS1 scan range cleavage agent details LTQ MOD MS:1001917 precursor mass tolerance ELISA fragment mass tolerance DIA HF SCIEX UNIMOD:4 UNIMOD:35 PRIDE MS:1001251 UNIMOD:737 UNIMOD MM RPPA UNIMOD:1 KR instrument MS2 analyzer type CS scan window lower limit MT scan window upper limit MRM SRM PSI UNIMOD:21 MSD MGF SHOULD FTP PP SILAC TA MS:1001306 ID TMT DDA TS data file fraction identifier SDRF PRIDE:0000663 modification parameters technical replicate label URL PRM CF REQUIRED NT"
  }
];
